¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ¼öÁ¤ »èÁ¦

»ï¼º¼­¿ïº´¿ø 2022 Samsung-Mayo Clinic Heart Symposium : 2022-10-22

ÃßõÇϱâ
¿¬¼ö°­Á À̹øÁÖ BEST
 
»ï¼º¼­¿ïº´¿ø 2022 Samsung-Mayo Clinic Heart Symposium : 2022-10-22
±³À°ÀÏÀÚ : 2022-10-22
±³À°Àå¼Ò : »ï¼º¼­¿ïº´¿ø º»°ü ÁöÇÏ1Ãþ ´ë°­´ç  
±³À°ÁÖÁ¦ : 2022 Samsung-Mayo Clinic Heart Symposium
ÁÖÃÖ±â°ü : »ï¼º¼­¿ïº´¿ø
½ÃÇà±â°ü(ÁöºÎ/°ú) : ¼øȯ±â³»°ú  
´ã´çÀÚ : ÀåÇý¼÷
¿¬¶ôó : 02-3410-3792  
À̸ÞÀÏ : hs0129.jang@samsung.com      
±³À°Á¾·ù : ³»°ú±âŸ
Âü¼®¿¹»óÀοø : 300¸í
Èñ¸ÁÆòÁ¡ : 5Á¡  
Áö¿ª : ¼­¿ïƯº°½Ã
±³À°½Ã°£ : 7 ½Ã°£ 15ºÐ  
¼¼ºÎ¼ö°­·á : 0¿ø      
ºñ°í       

±¸ºÐ ¿ùÀÏ °­ÀǽǠ½Ã°£ ±³À°Á¦¸ñ  °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 10-22 »ï¼º¼­¿ïº´¿ø º»°ü B1 ´ë°­´ç 08:45~09:00 Pathophysiology of HFpEF  Omar F. Abou Ezzeddine(Mayo Clinic, USA) 
±³À°½Ã°£ 10-22 »ï¼º¼­¿ïº´¿ø º»°ü B1 ´ë°­´ç 09:00~09:15 Cardiac Amyloidosis: diagnostic challenge  ±è´Ù·¡(»ï¼º¼­¿ïº´¿ø) 
±³À°½Ã°£ 10-22 »ï¼º¼­¿ïº´¿ø º»°ü B1 ´ë°­´ç 09:15~09:30 Coronary microvascular dysfunction in HFpEF  ÃÖ±âÈ«(»ï¼º¼­¿ïº´¿ø) 
±³À°½Ã°£ 10-22 »ï¼º¼­¿ïº´¿ø º»°ü B1 ´ë°­´ç 09:30~09:45 Excersise stress test in HFpEF  Jae K. Oh(Mayo Clinic, USA) 
±³À°½Ã°£ 10-22 »ï¼º¼­¿ïº´¿ø º»°ü B1 ´ë°­´ç 09:45~10:00 Promising treatment candidates in HFpEF  Atta Behfar(Mayo Clinic, USA) 
Åä·Ð 10-22 »ï¼º¼­¿ïº´¿ø º»°ü B1 ´ë°­´ç 10:00~10:30 Discussion  () 
È޽Ġ10-22 »ï¼º¼­¿ïº´¿ø º»°ü B1 ´ë°­´ç 10:30~10:45 Coffee break  () 
±³À°½Ã°£ 10-22 »ï¼º¼­¿ïº´¿ø º»°ü B1 ´ë°­´ç 10:45~11:00 Acute RV failure : assessment and management with critical care medicine   À强¾Æ(»ï¼º¼­¿ïº´¿ø) 
±³À°½Ã°£ 10-22 »ï¼º¼­¿ïº´¿ø º»°ü B1 ´ë°­´ç 11:00~11:15 New tools to prevent SCD: the Extravascular ICD   Paul A. Friedman(Mayo Clinic, USA) 
±³À°½Ã°£ 10-22 »ï¼º¼­¿ïº´¿ø º»°ü B1 ´ë°­´ç 11:15~11:30 Diagnostic conundrums in HFrEF: My tip and tricks  Omar F. Abou Ezzeddine(Mayo Clinic, USA) 
±³À°½Ã°£ 10-22 »ï¼º¼­¿ïº´¿ø º»°ü B1 ´ë°­´ç 11:30~11:45 Latest update on new medical treatment in HFrEF  ÃÖÁø¿À(»ï¼º¼­¿ïº´¿ø) 
±³À°½Ã°£ 10-22 »ï¼º¼­¿ïº´¿ø º»°ü B1 ´ë°­´ç 11:45~12:00 Revascularization strategy in ischemic cardiomyopathy: CABG PCI OMT  ÀÌÁÖ¸í(»ï¼º¼­¿ïº´¿ø) 
±³À°½Ã°£ 10-22 »ï¼º¼­¿ïº´¿ø º»°ü B1 ´ë°­´ç 12:00~12:15 From Silicone to Clinical Trials and Bedside to Home: AI to predict and detect ventricular dysfunction.  Paul A. Friedman(Mayo Clinic, USA) 
Åä·Ð 10-22 »ï¼º¼­¿ïº´¿ø º»°ü B1 ´ë°­´ç 12:15~12:45 Discussion  () 
½Ä»ç 10-22 »ï¼º¼­¿ïº´¿ø º»°ü B1 ´ë°­´ç 12:45~13:30 Lunch  () 
±³À°½Ã°£ 10-22 »ï¼º¼­¿ïº´¿ø º»°ü B1 ´ë°­´ç 13:30~13:45 CRT in NYHA IV patients on inotropes  ¹Ú½ÂÁ¤(»ï¼º¼­¿ïº´¿ø) 
±³À°½Ã°£ 10-22 »ï¼º¼­¿ïº´¿ø º»°ü B1 ´ë°­´ç 13:45~14:00 TAVR in congestive heart failure  Mayra Guerrero(Mayo Clinic, USA) 
±³À°½Ã°£ 10-22 »ï¼º¼­¿ïº´¿ø º»°ü B1 ´ë°­´ç 14:00~14:15 Percutaneous intervention for severe MR and TR  Mayra Guerrero(Mayo Clinic, USA) 
±³À°½Ã°£ 10-22 »ï¼º¼­¿ïº´¿ø º»°ü B1 ´ë°­´ç 14:15~14:30 Optimal weaning strategy in VA ECMO  ¾çÁ¤ÈÆ(»ï¼º¼­¿ïº´¿ø) 
±³À°½Ã°£ 10-22 »ï¼º¼­¿ïº´¿ø º»°ü B1 ´ë°­´ç 14:30~14:45 Optimal maintenance therapy after LVAD implantation  Atta Behfar(Mayo Clinic, USA) 
Åä·Ð 10-22 »ï¼º¼­¿ïº´¿ø º»°ü B1 ´ë°­´ç 14:45~15:15 Discussion  () 
È޽Ġ10-22 »ï¼º¼­¿ïº´¿ø º»°ü B1 ´ë°­´ç 15:15~15:30 Coffee break  () 
±³À°½Ã°£ 10-22 »ï¼º¼­¿ïº´¿ø º»°ü B1 ´ë°­´ç 15:30~15:45 Artificial Intelligence Basics: What the Clinician needs to know.  ±èÁÖ¿¬(»ï¼º¼­¿ïº´¿ø) 
±³À°½Ã°£ 10-22 »ï¼º¼­¿ïº´¿ø º»°ü B1 ´ë°­´ç 15:45~16:00 Current status of Echo AI  Jae K. Oh(Mayo Clinic, USA) 
±³À°½Ã°£ 10-22 »ï¼º¼­¿ïº´¿ø º»°ü B1 ´ë°­´ç 16:00~16:15 Current status of Hemodynamic monitoring AI  ±ÇÁظí(¸ÞµðÄÿ¡À̾ÆÀÌ/¼¼Á¾º´¿ø) 
±³À°½Ã°£ 10-22 »ï¼º¼­¿ïº´¿ø º»°ü B1 ´ë°­´ç 16:15~16:30 Machine Learning to Assist Accurate Clinical Decision in valvular heart disease  À̽ÂÇ¥(¼­¿ï´ëº´¿ø) 
±³À°½Ã°£ 10-22 »ï¼º¼­¿ïº´¿ø º»°ü B1 ´ë°­´ç 16:30~16:45 AI to Find Hidden Atrial Fibrillation: State of the Art  Paul A. Friedman(Mayo Clinic, USA) 
Åä·Ð 10-22  16:45~17:15 Discussion  () 
ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
" »ï¼º¼­¿ïº´¿ø 2022 Samsung-Mayo Clinic Heart Symposium : 2022-10-22""ÀÇ ÀÌ¿ëÈı⳪ Ãßõ´ñ±ÛÀ» ³²°Ü À¯¿ëÇÑ Á¤º¸·Î °øÀ¯ÇսôÙ. ^^
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ¼öÁ¤ »èÁ¦
ÀÌÀü±Û (¿Â¶óÀÎ) 2022 Çѱ¹ºÐ¼®½É¸®ÇÐȸ Ãß°èÇмú´ëȸ : 2022-10-22
´ÙÀ½±Û Á¦7Â÷ ´ëÇѼչßÅéÇÐȸ Çмú´ëȸ : 2022-10-22
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
21030 ¼­¿ï Á¦31ȸ ´ëÇѱâÃÊÀÇÇÐ Çмú´ëȸ (2ÀÏÂ÷) - ¿Â/¿ÀÇÁ º´Çà : 2024-06-28 0 5 2024-06-18
21029 ´ë±¸ 2024 ´ëÇÑÀÀ±ÞÀÇÇÐȸ Ãá°èÇмú´ëȸ (2ÀÏÂ÷) : 2024-06-28 0 4 2024-06-18
21028 ¼­¿ï 2024 ´ëÇÑ ¼Ò¾Æ¾Ë·¹¸£±â È£Èí±âÇÐȸ Ãá°èÇмú´ëȸ 1ÀÏÂ÷ : 2024-06-28 0 10 2024-06-18
21027 ºÎ»ê ´ëÇѽÉÀåÇÐȸ ±âÃÊ°úÇבּ¸È¸ ÇÏ°è½ÉÆ÷Áö¾ö 2024 : 2024-06-28 0 6 2024-06-18
21026 ¼­¿ï (¿Â¶óÀÎ) ´ëÇѼҾƳ»ºÐºñÇÐȸ ºñ¸¸¿¬±¸Áý´ãȸ 2024³â 1Â÷ : 2024-06-27 0 6 2024-06-18
21025 ¼­¿ï (¿Â¶óÀÎ) 2024³â ´ëÇÑ°øÁߺ¸°ÇÀÇ»çÇùÀÇȸ 3Â÷ ¿Â¶óÀÎ ÇÏ°è Çмú´ëȸ (1ÀÏÂ÷) : 2024-06-27 0 2 2024-06-18
21024 ºÎ»ê Á¦11Â÷ ´ëÇÑ¿µ»óÀÇÇÐȸ Ãá°èÁ¾ÇÕ½ÉÆ÷Áö¾ö 1ÀÏÂ÷ : 2024-06-27 0 4 2024-06-18
21023 ´ë±¸ ´ëÇѹæ»ç¼±Á¾¾çÇÐȸ ´ë±¸°æºÏÁöȸ 3Â÷ Áý´ãȸ : 2024-06-27 0 4 2024-06-18
21022 ¼­¿ï ´ëÇѼҾƸ¶ÃëÇÐȸ ¿Â¶óÀÎ 2024³â Èñ±Í³­Ä¡ Áúȯ ¸¶Ãë ÇÁ·ÎÅäÄÝ ¿þºñ³ª : 2024-06-27 0 6 2024-06-18
21021 ¼­¿ï (1ÀÏÂ÷)2024³â ´ëÇÑô¼öÇÐȸ 2nd ISCoS Regional Symposium : 2024-06-27 0 6 2024-06-18
21020 °­¿ø 2024 ö¿ø±ºÀÇ»çȸ 2Â÷ ¿¬¼ö°­ÁÂ_ÃÖ±Ù ÀÇÇÐÁö°ß(Ä¡¸Å, ¹é³»Àå°ú ³ë¾È) 0 6 2024-06-18
21019 ¼­¿ï Á¦31ȸ ´ëÇѱâÃÊÀÇÇÐ Çмú´ëȸ (1ÀÏÂ÷) - ¿Â/¿ÀÇÁ º´Çà : 2024-06-27 0 4 2024-06-18
21018 ÀüºÏ ±º»ê½ÃÀÇ»çȸ ¿¬¼ö±³À°(±â´É¼º ¼ÒÈ­ºÒ·®Áõ, º¸Çè½É»çÀÇ ÃֽŠÀ̽´) : 2024-06-27 0 4 2024-06-18
21017 ´ë±¸ 2024 ´ëÇÑÀÀ±ÞÀÇÇÐȸ Ãá°èÇмú´ëȸ (1ÀÏÂ÷) : 2024-06-27 0 8 2024-06-18
21016 ºÎ»ê 2024 ±ÝÁ¤±¸ÀÇ»çȸ Çмú´ëȸ(¿¹¹æÁ¢Á¾, ÇʼöÀÇ·áÆÐÅ°Áö) : 2024-06-27 0 8 2024-06-18
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷